3 days ago · The continued decline of Merck & Co.’s HPV vaccine Gardasil in China has come to a head as the New Jersey drug giant is halting shipments to the world’s second-most populous country. Thanks to ...

3 days ago · Merck said it had stopped Gardasil shipments to China from this month. The company has previously said China's anti-bribery and anti-corruption drive, opens new tab had also hurt sales of the vaccine.

3 days ago · Gardasil, which prevents cancers caused by the human papillomavirus (HPV), has been one of Merck's top growth drivers aside from Keytruda, and much of its international growth had come from China ...

3 days ago · Merck & Co. shares tumbled after the company halted shipments to China of its cancer-preventing Gardasil vaccine, a dramatic escalation to the company’s problems in the country that threatens ...

2 days ago · Merck & Co.’s blockbuster vaccine Gardasil has had a roller-coaster ride in China. A post-Covid surge in demand for the cancer-preventing shot quickly deflated last year, to the point the US ...

3 days ago · Overall sales of Gardasil fell 17% to $1.55 billion in the final quarter of last year, mainly due to the lower demand in China. Gardasil vaccine protects against cancer-causing human papilloma virus or HPV infections. The pause announcement comes a month after Merck received approval in China for use of the vaccine in males.

3 days ago · China is the largest market for Gardasil outside of the U.S., accounting for 60% to 70% of overseas sales. Executives, however, remained optimistic about re-establishing growth in China. “China still represents a significant long-term opportunity for Gardasil given the large number of females, and now males with our recent approval, that are ...

3 days ago · Its fourth quarter Gardasil sales were $1.55 billion, below Wall Street's forecast of around $1.8 billion, which has been pared back nearly 20% since the issues in China were disclosed last summer.

Oct 31, 2024 · Merck attributed the decline to lower demand in China, which offset double-digit growth across “almost every other region,” CEO Robert Davis noted on the drugmaker’s third-quarter call Thursday.

The low end of Merck's revenue guidance assumes no further shipments in China, and less than $1 billion in sales at the high end. Merck CEO Robert Davis said on an earnings call that Gardasil ...